Biotoxtech Statistics

Total Valuation

Biotoxtech has a market cap or net worth of KRW 48.34 billion. The enterprise value is 76.66 billion.

Market Cap	48.34B
Enterprise Value	76.66B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Biotoxtech has 15.72 million shares outstanding. The number of shares has increased by 0.22% in one year.

Current Share Class	15.72M
Shares Outstanding	15.72M
Shares Change (YoY)	+0.22%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	14.74%
Owned by Institutions (%)	0.01%
Float	10.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.11
PB Ratio	1.49
P/TBV Ratio	1.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-11.59
EV / Sales	1.76
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.58

Financial Position

The company has a current ratio of 0.67, with a Debt / Equity ratio of 1.96.

Current Ratio	0.67
Quick Ratio	0.45
Debt / Equity	1.96
Debt / EBITDA	n/a
Debt / FCF	-6.31
Interest Coverage	-1.51

Financial Efficiency

Return on equity (ROE) is -30.96% and return on invested capital (ROIC) is -4.90%.

Return on Equity (ROE)	-30.96%
Return on Assets (ROA)	-3.54%
Return on Invested Capital (ROIC)	-4.90%
Return on Capital Employed (ROCE)	-15.47%
Revenue Per Employee	220.21M
Profits Per Employee	-33.40M
Employee Count	198
Asset Turnover	0.31
Inventory Turnover	3.24

Taxes

In the past 12 months, Biotoxtech has paid 3.48 billion in taxes.

Income Tax	3.48B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.87% in the last 52 weeks. The beta is 0.92, so Biotoxtech's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	-41.87%
50-Day Moving Average	2,940.80
200-Day Moving Average	3,501.90
Relative Strength Index (RSI)	58.21
Average Volume (20 Days)	18,765

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biotoxtech had revenue of KRW 43.60 billion and -6.61 billion in losses. Loss per share was -467.39.

Revenue	43.60B
Gross Profit	3.84B
Operating Income	-7.86B
Pretax Income	-8.63B
Net Income	-6.61B
EBITDA	-3.68B
EBIT	-7.86B
Loss Per Share	-467.39

Full Income Statement

Balance Sheet

The company has 29.34 billion in cash and 63.77 billion in debt, giving a net cash position of -34.43 billion or -2,189.89 per share.

Cash & Cash Equivalents	29.34B
Total Debt	63.77B
Net Cash	-34.43B
Net Cash Per Share	-2,189.89
Equity (Book Value)	32.52B
Book Value Per Share	2,457.20
Working Capital	-27.06B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.03 billion and capital expenditures -2.07 billion, giving a free cash flow of -10.11 billion.

Operating Cash Flow	-8.03B
Capital Expenditures	-2.07B
Free Cash Flow	-10.11B
FCF Per Share	-642.93

Full Cash Flow Statement

Margins

Gross margin is 8.81%, with operating and profit margins of -18.03% and -15.17%.

Gross Margin	8.81%
Operating Margin	-18.03%
Pretax Margin	-19.80%
Profit Margin	-15.17%
EBITDA Margin	-8.45%
EBIT Margin	-18.03%
FCF Margin	n/a

Dividends & Yields

Biotoxtech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.22%
Shareholder Yield	n/a
Earnings Yield	-13.68%
FCF Yield	-20.91%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biotoxtech has an Altman Z-Score of 0.28 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.28
Piotroski F-Score	3